Alnylam Pharmaceuticals
Mick Flanagan is an experienced executive in the biopharmaceutical industry, currently serving as Vice President of Global Manufacturing at Alnylam Pharmaceuticals since September 2021. Prior to this role, Mick Flanagan held various leadership positions at MSD from September 2018 to September 2021, including Site Lead for MSD Biotech Dublin and MSD Site Lead for Biologics. Mick Flanagan's career includes significant tenure at Bristol-Myers Squibb, where roles spanned from Manufacturing Director for Biologics and API to Production Building Manager for API between 2000 and 2018. Mick Flanagan obtained a Bachelor of Science degree in Chemistry and Mathematics (joint honours) from Maynooth University from 1986 to 1990.
Alnylam Pharmaceuticals
32 followers
Alnylam is the world's leading RNAi therapeutics company and the first and only company to bring an RNAi medicine to market.